Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 11:35:20 2024-05-06 am EDT			5-day change	1st Jan Change
39.61 ^EUR	+0.89%		+5.85%	+4.35%

May. 03	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	MT
May. 03	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reaffirms its Sell rating	ZD

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies

April 26, 2024 at 03:02 am EDT

Jefferies analyst reiterate his Sell rating on the stock. The target price is increased from EUR 29 to EUR 32.

Latest news about Fresenius Medical Care AG

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	May. 03	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reaffirms its Sell rating	May. 03	ZD
Fresenius to Sell 67% of Vamed's Rehabilitation Business to PAI Partners	May. 03	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	Apr. 29	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies	Apr. 26	ZD
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 24	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs keeps its Buy rating	Apr. 23	ZD
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	Apr. 22	MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	Apr. 22	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : DZ Bank sticks Neutral	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from Jefferies	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays gives a Neutral rating	Apr. 22	ZD
Berenberg rates FMC at 'Buy' - Target 47 euros	Apr. 22	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Berenberg	Apr. 22	ZD
Positive trend of FMC and Fresenius continues	Apr. 22	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reiterates its Sell rating	Apr. 19	ZD
STOXX 600 nears six-week low on geopolitical jitters; Ericsson shines	Apr. 16	RE
Fresenius at a two-month high - Tyenne launch and fantasy figures	Apr. 16	DP
Fresenius at two-month high - Tyenne launch a milestone	Apr. 16	DP
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	Apr. 15	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan gives a Sell rating	Apr. 04	ZD
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	Mar. 21	MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-05-06 - Q1 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Barebone 2023 profitability is a much lower starting point

February 21, 2024 at 04:12 am EST

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

39.61 EUR

Average target price

39.4 EUR

Spread / Average Target

-0.53%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	+4.35%	12.41B
HCA HEALTHCARE, INC.	+14.55%	80.61B
CVS HEALTH CORPORATION	-29.12%	70.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.76%	29.12B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-11.55%	16.97B
FRESENIUS SE & CO. KGAA	-0.71%	16.96B
QUEST DIAGNOSTICS INCORPORATED	-1.62%	15.26B
PURE HEALTH HOLDING	-30.88%	11.95B
REDE D'OR SÃO LUIZ S.A.	-5.39%	11.93B
NATERA, INC.	+55.19%	11.85B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies

EPS Revisions